CD276 was knockeddown in ccRCC cell models (sunitinib-resistant 786-O/R cells andsunitinib-sensitive 786-O cells) using shRNA transfection, and the cells wereexposed to a sunitinib (2 μM) environment. Here, CD276 is linked to nonpapillary renal cell carcinoma.